Monto A - Search Results

1

Progression of biopsy-measured liver fibrosis in untreated patients with hepatitis C infection: non-Markov multistate model analysis.

Bacchetti P, Boylan R, Astemborski J, Shen H, Mehta SH, Thomas DL, Terrault NA, Monto A. Bacchetti P, et al. Among authors: monto a. PLoS One. 2011;6(5):e20104. doi: 10.1371/journal.pone.0020104. Epub 2011 May 27. PLoS One. 2011. PMID: 21637766 Free PMC article.

2

Hepatitis C and steatosis.

Monto A. Monto A. Semin Gastrointest Dis. 2002 Jan;13(1):40-6. Semin Gastrointest Dis. 2002. PMID: 11944633 Review.

3

Risks of a range of alcohol intake on hepatitis C-related fibrosis.

Monto A, Patel K, Bostrom A, Pianko S, Pockros P, McHutchison JG, Wright TL. Monto A, et al. Hepatology. 2004 Mar;39(3):826-34. doi: 10.1002/hep.20127. Hepatology. 2004. PMID: 14999703

4

Contributions to hepatic fibrosis in HIV-HCV coinfected and HCV monoinfected patients.

Monto A, Kakar S, Dove LM, Bostrom A, Miller EL, Wright TL. Monto A, et al. Am J Gastroenterol. 2006 Jul;101(7):1509-15. doi: 10.1111/j.1572-0241.2006.00613.x. Am J Gastroenterol. 2006. PMID: 16863554

5

The association of human immunodeficiency virus infection with spontaneously resolved hepatitis C virus infection and level of viremia among injection drug users.

Seal KH, Monto A, Dove L, Shen H, Vittinghoff E, Tracy D, Miller E, Lau E, Wright TL. Seal KH, et al. Among authors: monto a. Dig Dis Sci. 2007 Dec;52(12):3423-30. doi: 10.1007/s10620-006-9277-z. Epub 2007 Apr 19. Dig Dis Sci. 2007. PMID: 17443407

6

A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus.

Currie SL, Ryan JC, Tracy D, Wright TL, George S, McQuaid R, Kim M, Shen H, Monto A. Currie SL, et al. Among authors: monto a. Drug Alcohol Depend. 2008 Jan 11;93(1-2):148-54. doi: 10.1016/j.drugalcdep.2007.09.011. Epub 2007 Oct 30. Drug Alcohol Depend. 2008. PMID: 17977668

7

Hepatocellular carcinoma after sustained virologic response in hepatitis C patients without cirrhosis on a pretreatment liver biopsy.

Sewell JL, Stick KM, Monto A. Sewell JL, et al. Among authors: monto a. Eur J Gastroenterol Hepatol. 2009 Feb;21(2):225-9. doi: 10.1097/MEG.0b013e32831101b7. Eur J Gastroenterol Hepatol. 2009. PMID: 19212213 Free PMC article.

8

Non-Markov multistate modeling using time-varying covariates, with application to progression of liver fibrosis due to hepatitis C following liver transplant.

Bacchetti P, Boylan RD, Terrault NA, Monto A, Berenguer M. Bacchetti P, et al. Among authors: monto a. Int J Biostat. 2010 Feb 20;6(1):Article 7. doi: 10.2202/1557-4679.1213. Int J Biostat. 2010. PMID: 20305705 Free PMC article.

9

Retreatment of hepatitis C with consensus interferon and ribavirin after nonresponse or relapse to pegylated interferon and ribavirin: a national VA clinical practice study.

Yee HS, Currie SL, Tortorice K, Cozen M, Shen H, Chapman S, Cunningham F, Monto A. Yee HS, et al. Among authors: monto a. Dig Dis Sci. 2011 Aug;56(8):2439-48. doi: 10.1007/s10620-011-1746-3. Epub 2011 Jun 2. Dig Dis Sci. 2011. PMID: 21633833

10

Impaired lymphocyte reactivity measured by immune function testing in untransplanted patients with cirrhosis.

Yee RM, Lehil MS, Rongey C, Shen H, Cozen ML, Monto A, Ryan JC. Yee RM, et al. Among authors: monto a. Clin Vaccine Immunol. 2013 Apr;20(4):526-9. doi: 10.1128/CVI.00595-12. Epub 2013 Feb 6. Clin Vaccine Immunol. 2013. PMID: 23389930 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

490 results

Search Page

Filters